Image

A Phase III Randomized Trial Comparing Adjuvant MK-3475 (Pembrolizumab) to Standard of Care Observation in Completely Resected Merkel Cell Carcinoma

Study on the Effectiveness of an Investigational Medication for Merkel Cell Cancer

Recruiting
18 years and older
All
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the effectiveness of an investigational medication compared to standard observation in patients with stages I-III Merkel cell cancer. Merkel cell cancer is a rare type of skin cancer that can grow quickly and spread to other parts of the body. The study focuses on patients whose cancer has been completely removed by surgery.

Participants in this study will receive either the investigational medication, which is a type of immunotherapy using monoclonal antibodies, or they will continue with standard observation. Immunotherapy may help the immune system attack cancer cells and prevent them from growing and spreading.

  • Who can participate: Adults with stage I-III Merkel cell cancer that has been completely removed by surgery may participate. Participants must not have distant metastatic disease or have received previous systemic or radiation therapy for Merkel cell carcinoma. Women must not be pregnant or breastfeeding, and effective contraception is required for those of childbearing potential.
  • Study details: Participants will be assigned to receive either the investigational medication or continue with standard observation. The investigational medication is a type of immunotherapy that uses monoclonal antibodies to help the immune system fight cancer.
Print
Study details
    Merkel Cell Carcinoma

TX10161

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.